开放存取 开放存取  受限制的访问 ##reader.subscriptionAccessGranted##  受限制的访问 订阅或者付费存取

编号 10 (2017)

Articles

NEWS OF MEDICINE

- -.
Pharmateca. 2017;(10):4-5
pages 4-5 views

ANTIBAKTERIAL'NAYa TERAPIYa PRI VNEBOL'NIChNOY PNEVMONII: SOVREMENNOE SOSTOYaNIE PROBLEMY

- -.

摘要

Несмотря на очевидные прорывы и успехи в лечении внебольничных пневмоний (ВП), проблема растущей резистентности антибиотиков требует своевременного пересмотра позиций и руководящих принципов. Повышению эффективности антибактериальной терапии пациентов с острой и затяжной ВП был посвящен научный симпозиум в рамках XXIV Российского национального конгресса «Человек и лекарство» (10-13 апреля 2017 г., Москва). Открывая симпозиум, академик РАН, директор ФГБУ НИИ пульмонологии ФМБА России, заведующий кафедрой госпитальной терапии педиатрического факультета ФГБОУ ВО РНИМУ им. Н.И. Пирогова МЗ России Александр Григорьевич Чучалин отметил, что на проблему антибактериальной терапии в лечении ВП необходимо смотреть сквозь призму знаний с учетом позиций разных сторон.
Pharmateca. 2017;(10):6-11
pages 6-11 views

THE USE OF ROSUVASTATIN IN PATIENTS WITH HYPERCHOLESTEROLEMIA (IIA AND IIB TYPE HYPERLIPDEMIA, FAMILIAL HYPERCHOLESTERINEMIA) IN CLINICAL OUTPATIENT PRACTICE

Rozhkova T., Kaminnaya V., Zubareva M.

摘要

The article presents an algorithm for diagnostics of hypercholesterolemia for targeted lipid-lowering therapy with statins, including rosuvastatin, in patients of different risk groups for cardiovascular complications in clinical outpatient practice for the purpose of primary and secondary prevention of CVDs. The study included patients with different variants of hyperlipidemia. Methods of routine clinical examination and diagnostics of familial hypercholesterolemia were used. An evaluation of lipid-lowering therapy using various statins, including rosuvastatin, was conducted to determine the individual adherence of therapy during clinical follow-up of patients. Insufficient awareness of patients about the need for effective lipid-lowering therapy and insufficient identification of patients with familial hypercholesterolemia for primary prevention of cardiovascular complications were revealed.
Pharmateca. 2017;(10):12-19
pages 12-19 views

MODERN VIEWS ON THE USE OF DORIPENEM IN CLINICAL PRACTICE

Stetsyuk O., Andreeva I., Kozlov R.

摘要

The ubiquitous appearance and rapid spread of nosocomial gram-negative pathogens with multiple resistance to antimicrobial agents is an extremely alarming trend throughout the world. In this regard, health care systems of all countries face an issue of most efficient use of available antibacterial drugs in hospitals, and first of all it concerns carbapenems. The article presents information on the comparative antimicrobial activity of imipenem, meropenem and doripenem in relation to problem Gram-negative pathogens, and discusses the most relevant options for increasing the effectiveness of doripenem in clinical practice, namely, the use of higher doses of antibiotic, the extensive introduction of extended infusion and the use of combination therapy with simultaneous administration of several antimicrobial agents (including two carbapenems).
Pharmateca. 2017;(10):20-28
pages 20-28 views

EXPERIENCE OF THE USE OF CAVINTON COMFORTE IN THE TREATMENT OF CHRONIC CEREBROVASCULAR INSUFFICIENCY

Vakhnina N., Milovanova O.

摘要

Chronic cerebrovascular insufficiency (CCVI) is a very common neurological pathology, especially among elderly patients. Currently, there are different approaches to the formulation and criteria for clinical diagnosis in this pathology. Its development is mainly associated with small vessel damage, which leads to the development of silent infarcts and progressive diffuse leukoencephalopathy. The main clinical manifestations of CCVI include vascular cognitive impairment, ambulation disorders and postural instability. Treatment should be directed to a underlying vascular disease and include vasotropic and neurometabolic therapy, and non-drug approaches (mental and physical activity, lifestyle optimization). The possibility of use of vinpocetine dispersible tablets (Cavinton® Comforte) in CCVI are considered.
Pharmateca. 2017;(10):29-33
pages 29-33 views

EFFICACY OF THE USE OF HYDROACTIVE DRESSINGS IN STAGE TREATMENT OF TROPHIC ULCERS IN PATIENTS WITH LOWER EXTREMITY VARICOSE VEIN DISEASE

Malakhov Y.

摘要

The article presents a clinical example of the use of modern wound dressings HydroClean plus and Hydro Tac (Paul Hartman, Germany) for the local treatment of venous ulcers. This clinical observation showed high clinical effectiveness of wound dressings HydroClean plus and HydroTac in the treatment of venous trophic ulcers. The innovative structure of these dressings corresponds to modern views on the etiopathogenesis of chronic wounds against the background of decompensation of venous circulation, allows evacuating the exudate and toxic components from the wound, while maintaining high humidity and ensuring proper gas exchange.
Pharmateca. 2017;(10):34-38
pages 34-38 views

RUSSIAN EXPERIENCE OF QUALITATIVE DETERMINATION OF HEART-TYPE FATTY ACID-BINDING PROTEIN CONCENTRATIONS FOR EARLY DIAGNOSTICS OF MYOCARDIAL INFARCTION

Kokorin V.

摘要

The article considers the experience of Russian centers in the early diagnosis and prognosis of acute coronary syndrome (ACS) using heart-type fatty acid-binding protein (hFABP) levels. Pooled data of more than 3300 patients with ACS with and without ST segment elevation at both the inpatient and outpatient stages of healthcare delivery are presented. High performance indicators of the basic characteristics of the test allow to recommend it for wider application in clinical practice, especially in the early periods of ACS. The most useful is the use of qualitative rapid tests for the determination of hFABP in patients with atypical ACS and the absence of reliable ECG changes.
Pharmateca. 2017;(10):39-44
pages 39-44 views

EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN THE TYUMEN REGION OVER PERIOD OF 2007-2016

Lebedeva D., Brynza N., Nemkov A., Potapov A., Akarachkova E., Andreeva O., Orlova A.

摘要

Epidemiological studies of recent decades have convincingly confirmed that cardiovascular diseases are one of the leading causes of early disability and mortality of the population. Based on the statistical data of the Healthcare Department of the Tyumen Region over period of 2007-2016, an epidemiological assessment of indicators of circulatory diseases (CD) and cerebrovascular disease (CVD) in the Tyumen Region was performed. It was revealed that the mortality rates for CD and CVD in the region were less than the average rates in Russia, with significantly higher rates for the rural population compared to the urban population. The mortality rates for these diseases among men were also significantly higher than among women, while in 2016 the mortality rates for CVD have significantly decreased in both men and women, demonstrating the effectiveness of the healthcare system in organization of rehabilitation and preventive activities in the region. Further implementation of strategies aimed at improving epidemiological indicators will reduce the CVD burden.
Pharmateca. 2017;(10):45-49
pages 45-49 views

LONG-TERM RESULTS OF USE OF FABOMOTIZOLE IN THE TREATMENT OF ANXIETY-DEPRESSIVE DISORDERS IN PATIENTS ON PROGRAM HEMODIALYSIS

Belousova I., Borovkov N.

摘要

Anxiety-depressive disorders (ADR) in patients on programmed hemodialysis are the most common mental disorders. The article describes the results of the use of fabomotizole by this cohort of patients during follow-up: immediately after treatment, and 1 and 2 months after treatment. It was found that this drug significantly reduced the severity of anxiety and depression in dialysis patients, but 2 months after the therapy, signs of ADR were revealed again, requiring re-correction with fabomotizole and counseling of the psychotherapeutist.
Pharmateca. 2017;(10):50-53
pages 50-53 views

CLINICAL AND PHARMACOLOGICAL APPROACHES TO THE TREATMENT OF CHRONIC BRONCHITIS

Ignatova G., Dorfman I., Kazakova S., Orlova E., Kirilochev O.
Pharmateca. 2017;(10):54-57
pages 54-57 views

CLINICAL CASE OF TRANSTHYRETIN AMYLOIDOSIS WITH HEART, PLEVURE AND KIDNEY INVOLVEMENT

Ivanova M., Bolduyeva S., Ikonnikov P.

摘要

The article presents a case of systemic amyloidosis with heart (cardiomyopathy), pleura and kidney involvement in a 73-year-old female patient, in which the amyloid precursor protein was transthyretin, normally transporting thyroxine and retinol. The leading clinical manifestation of the disease was treatment-resistant hydrothorax. There is no information on the effective treatment of transthyretine amyloidosis in the literature. 8 months after the establishing diagnosis and 22 months after the appearance of the first clinical manifestations of the disease, the patient died from progressive cardiopulmonary insufficiency.
Pharmateca. 2017;(10):58-60
pages 58-60 views

THE USE OF LEVOFLOXACINE IN OTORHINOLARYNGOLOGY: FEATURES AND ADVANTAGES

Tarasova G.

摘要

The article discusses the problem of the use of fluoroquinolones in otorhinolaryngology. It has been established that the number of prescriptions of levofloxacin continues to grow in the world. The reason for the increase in the use of levofloxacin includes its more favorable benefit/risk ratio compared to many other fluoroquinolones as evidenced by the results of not only clinical but also ongoing pharmacoepidemiological studies.
Pharmateca. 2017;(10):61-65
pages 61-65 views

ARRANGEMENTS FOR THE USE OF RECOURSES OF THE COMPULSORY MEDICAL INSURANCE FUND FOR OBTAINING ADDITIONAL PROFESSIONAL EDUCATION BY MEDICAL AND PHARMACEUTICAL SPECIALISTS

Pischita A.

摘要

Due to the transition of additional professional education to the system of continuous medical education, new methods and forms of training have been introduced into the practice of professional development of medical and pharmaceutical specialists. In addition, the employer now has new opportunities to fund training programs for specialists. The rights of medical and pharmaceutical workers to the choice of educational programs for additional professional education and an educational organization have been expanded. The article considers the new possibilities of system of continuous medical education in the Russian public health service.
Pharmateca. 2017;(10):66-70
pages 66-70 views
##common.cookie##